Creative Medical Technology Holdings (CELZ) Long-Term Debt Issuances (2016 - 2021)
Creative Medical Technology Holdings (CELZ) has disclosed Long-Term Debt Issuances for 11 consecutive years, with $3.7 million as the latest value for Q3 2021.
- On a quarterly basis, Long-Term Debt Issuances changed N/A to $3.7 million in Q3 2021 year-over-year; TTM through Jun 2022 was $3.7 million, a N/A change, with the full-year FY2021 number at $3.9 million, changed N/A from a year prior.
- Long-Term Debt Issuances was $3.7 million for Q3 2021 at Creative Medical Technology Holdings, up from $22000.0 in the prior quarter.
- In the past five years, Long-Term Debt Issuances ranged from a high of $3.7 million in Q3 2021 to a low of -$368050.0 in Q4 2017.
- A 4-year average of $535660.2 and a median of $306452.5 in 2019 define the central range for Long-Term Debt Issuances.
- Peak YoY movement for Long-Term Debt Issuances: tumbled 200.45% in 2017, then soared 9679.2% in 2018.
- Creative Medical Technology Holdings' Long-Term Debt Issuances stood at -$368050.0 in 2017, then soared by 215.98% to $426855.0 in 2018, then plummeted by 40.14% to $255500.0 in 2019, then skyrocketed by 1332.97% to $3.7 million in 2021.
- Per Business Quant, the three most recent readings for CELZ's Long-Term Debt Issuances are $3.7 million (Q3 2021), $22000.0 (Q1 2021), and $255500.0 (Q4 2019).